Unlike what was observed for inflammatory cytokine content, soluble proangiogenic factors assayed (FGF-2, HGF, and ANGPT-2) were constitutively expressed in the UI corneas and did not change as a result of VEH or AP20187 treatment following infection (Figs. 5D–F). The gene discussed is HGF; the disease is infection.